CRISPR Therapeutics AG (CRSP)
SEC filings, insider trading & institutional ownership from EDGAR.
Institutions
42
$2.67B held
Latest filings
10-K, 10-Q, 8-K, Form 4 & 13D/G. Sourced directly from SEC EDGAR
No filings are available yet.
Top holders
13F & 13D/G · latest quarter
| Holder | Filed | Value |
|---|---|---|
| ARK Investment Management LLC | Aug 14, 2026 | $516.00M |
| BlackRock, Inc. | Aug 7, 2026 | $455.35M |
| Capital World Investors | Aug 12, 2026 | $259.04M |
| STATE STREET CORPORATION | Aug 7, 2026 | $235.70M |
| GEODE CAPITAL MANAGEMENT, LLC | Aug 12, 2026 | $136.92M |
CRSP's filings are public. The insight is one click away.
Scrutar's AI reads every CRSP filing and surfaces what matters. Red flags, risk shifts, disclosure quality and key relationships. Cited to the source, free with an account.
Red Flag Detection20+ forensic checks per filingRisk RadarYear-over-year changes in risk factorsFiling DNADisclosure quality scored across six dimensionsSupply Chain GraphCustomers, suppliers & competitors mapped
Analyze CRSP filingsNo credit cardAI reports included on the free plan
Never miss a CRSP filing.
Get an email when CRSP files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Data as of Sep 15, 2026Source: SEC EDGAR.